US Stock MarketDetailed Quotes

FibroBiologics (FBLG)

Watchlist
  • 0.9310
  • -0.0330-3.42%
Close Jun 12 16:00 ET
  • 0.9000
  • -0.0310-3.33%
Post 19:28 ET
4.85MMarket Cap-0.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

FibroBiologics (FBLG) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.85%5.07M
21.20%16.65M
-30.23%2.59M
50.30%5.04M
39.27%4.49M
31.33%4.53M
54.54%13.74M
49.68%3.71M
63.35%3.35M
54.04%3.22M
Selling and administrative expenses
-23.12%2.12M
0.10%9.24M
-23.90%1.79M
5.14%2.25M
8.89%2.45M
10.48%2.75M
41.59%9.23M
38.02%2.36M
44.43%2.14M
45.47%2.25M
-General and administrative expense
-23.12%2.12M
0.10%9.24M
-23.90%1.79M
5.14%2.25M
8.89%2.45M
10.48%2.75M
41.59%9.23M
38.02%2.36M
44.43%2.14M
45.47%2.25M
Research and development costs
65.90%2.95M
64.45%7.41M
-41.22%797K
129.93%2.79M
109.33%2.04M
85.42%1.78M
90.20%4.5M
75.42%1.36M
112.43%1.21M
78.24%975K
Operating profit
-11.85%-5.07M
-21.20%-16.65M
30.23%-2.59M
-50.30%-5.04M
-39.27%-4.49M
-31.33%-4.53M
-54.54%-13.74M
-49.68%-3.71M
-63.35%-3.35M
-54.04%-3.22M
Net non-operating interest income expense
-83.84%16K
-81.39%43K
-414.04%-179K
-1.35%73K
-23.08%50K
182.86%99K
257.14%231K
5,800.00%57K
74K
750.00%65K
Non-operating interest income
-79.80%20K
-1.59%247K
-60.32%25K
-7.59%73K
-28.57%50K
153.85%99K
--251K
--63K
--79K
--70K
Non-operating interest expense
--4K
920.00%204K
3,300.00%204K
--0
--0
--0
-86.39%20K
500.00%6K
--5K
-50.00%5K
Other net income (expense)
109.74%52K
-186.99%-2.04M
-185.43%-475K
-129.27%-813K
-105.37%-218K
89.42%-534K
131.48%2.35M
107.68%556K
2,070.21%2.78M
7,217.54%4.06M
Gain on sale of security
165.06%54K
-93.85%352K
-83.74%329K
-98.81%33K
-98.19%73K
---83K
179.08%5.72M
--2.02M
--2.78M
--4.03M
Other non- operating income (expenses)
99.56%-2K
29.17%-2.39M
45.19%-804K
-42,400.00%-846K
-1,070.00%-291K
91.06%-451K
-1,485.45%-3.38M
---1.47M
101.42%2K
152.63%30K
Income before tax
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
Income tax
Net income
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
Net income continuous Operations
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
Minority interest income
Net income attributable to the parent company
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
32.30%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
Net income attributable to common stockholders
-0.68%-5M
-67.06%-18.65M
-4.68%-3.24M
-1,055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
41.44%-11.16M
68.11%-3.1M
77.20%-500K
141.57%898K
Basic earnings per share
50.92%-1.33
-23.53%-8.4
66.67%-0.6
-1,200.00%-2.6
-500.00%-2.4
49.81%-2.71
42.06%-6.8
69.92%-1.8
85.19%-0.2
145.11%0.6
Diluted earnings per share
50.92%-1.33
-23.53%-8.4
66.67%-0.6
-1,200.00%-2.6
-500.00%-2.4
49.81%-2.71
42.06%-6.8
69.92%-1.8
85.19%-0.2
145.11%0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.85%5.07M21.20%16.65M-30.23%2.59M50.30%5.04M39.27%4.49M31.33%4.53M54.54%13.74M49.68%3.71M63.35%3.35M54.04%3.22M
Selling and administrative expenses -23.12%2.12M0.10%9.24M-23.90%1.79M5.14%2.25M8.89%2.45M10.48%2.75M41.59%9.23M38.02%2.36M44.43%2.14M45.47%2.25M
-General and administrative expense -23.12%2.12M0.10%9.24M-23.90%1.79M5.14%2.25M8.89%2.45M10.48%2.75M41.59%9.23M38.02%2.36M44.43%2.14M45.47%2.25M
Research and development costs 65.90%2.95M64.45%7.41M-41.22%797K129.93%2.79M109.33%2.04M85.42%1.78M90.20%4.5M75.42%1.36M112.43%1.21M78.24%975K
Operating profit -11.85%-5.07M-21.20%-16.65M30.23%-2.59M-50.30%-5.04M-39.27%-4.49M-31.33%-4.53M-54.54%-13.74M-49.68%-3.71M-63.35%-3.35M-54.04%-3.22M
Net non-operating interest income expense -83.84%16K-81.39%43K-414.04%-179K-1.35%73K-23.08%50K182.86%99K257.14%231K5,800.00%57K74K750.00%65K
Non-operating interest income -79.80%20K-1.59%247K-60.32%25K-7.59%73K-28.57%50K153.85%99K--251K--63K--79K--70K
Non-operating interest expense --4K920.00%204K3,300.00%204K--0--0--0-86.39%20K500.00%6K--5K-50.00%5K
Other net income (expense) 109.74%52K-186.99%-2.04M-185.43%-475K-129.27%-813K-105.37%-218K89.42%-534K131.48%2.35M107.68%556K2,070.21%2.78M7,217.54%4.06M
Gain on sale of security 165.06%54K-93.85%352K-83.74%329K-98.81%33K-98.19%73K---83K179.08%5.72M--2.02M--2.78M--4.03M
Other non- operating income (expenses) 99.56%-2K29.17%-2.39M45.19%-804K-42,400.00%-846K-1,070.00%-291K91.06%-451K-1,485.45%-3.38M---1.47M101.42%2K152.63%30K
Income before tax -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K
Income tax
Net income -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K
Net income continuous Operations -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K
Minority interest income
Net income attributable to the parent company -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M32.30%-11.16M68.11%-3.1M77.20%-500K141.57%898K
Preferred stock dividends
Other preferred stock dividends 0000
Net income attributable to common stockholders -0.68%-5M-67.06%-18.65M-4.68%-3.24M-1,055.60%-5.78M-618.71%-4.66M41.30%-4.97M41.44%-11.16M68.11%-3.1M77.20%-500K141.57%898K
Basic earnings per share 50.92%-1.33-23.53%-8.466.67%-0.6-1,200.00%-2.6-500.00%-2.449.81%-2.7142.06%-6.869.92%-1.885.19%-0.2145.11%0.6
Diluted earnings per share 50.92%-1.33-23.53%-8.466.67%-0.6-1,200.00%-2.6-500.00%-2.449.81%-2.7142.06%-6.869.92%-1.885.19%-0.2145.11%0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -